The 199th PIFW, "Healthcare Innovate: Transforming Investments for Global Well-being," held on November 21, 2024, was a critical summit for healthcare investors. This pivotal event convened 30 leading experts to delve into recent transformations and investment shifts in the sector. The discussions illuminated strategies for blending profit with patient care, navigating the complexities of technology transfer and harnessing the latest advancements in biotech investing.

3 Ways to Mitigate Risks in Healthcare Innovation

1. Purpose-Driven Advisory Boards - John H. Abeles, CEO at MedVest Group Inc, US, stresses the importance of crafting advisory boards with a clear purpose and vision. Selecting members with specialized expertise in areas like technology, medicine, or computational fields is crucial. Additionally, these boards should dynamically evolve to align with the company’s changing needs, ensuring their impact remains strong and relevant.

2. Leveraging Diverse Expertise - Diversity in advisory boards is vital, according to Dr. Prasun Mishra, Founding Director at Agility Pharmaceuticals, US. Boards that include a mix of domain experts can preemptively identify and tackle challenges, preventing costly mistakes. This approach ensures a well-rounded understanding of the technological applications and enhances the innovation process.

3. Strategic Insight on Advisory Boards - Incorporating strategic expertise into advisory boards can significantly diminish the risks associated with healthcare innovation. Abeles highlights the benefit of including members who understand both technology and market nuances. Such strategic insight helps navigate complex challenges, guiding companies more smoothly through innovation hurdles.

We extend our gratitude to our speakers for sharing their invaluable insights at the forum:

Lisa Morris

John H Abeles

Prasun Mishra

Yoav Fisher

We express our gratitude to the presenters for showcasing their investment opportunities at the event:

Xavier Wartelle, Co-Founder and CEO at Avatar Medical, US and his initiative to create patient avatars to help surgeons prepare, plan and control the quality of their surgeries. 

Brian Keane, Chairman at Diagen AI, US and his AI-driven protein design platform developing new biological molecules to reshape the health market.

Fahad Attar, Managing Director at OSOM, UK and his innovative project with regenerative orthopedics and precision health clinic, Regenesiss.

These insightful takes were shared during the 199th Private Investment Forum Worldwide. To have access to first-hand insights from top investment leaders, be sure to check our schedule and register for one of our upcoming events.